pemetrexed viatris 25 mg/ml concentrate for solution for infusion(4ml)
viatris limited damastown industrial park, mulhuddart, dublin 15, dublin, ireland - concentrate for solution for infusion - pemetrexed 25 mg/ml - antineoplastic agents
pemetrexed viatris 25 mg/ml concentrate for solution for infusion(20ml)
viatris limited damastown industrial park, mulhuddart, dublin 15, dublin, ireland - concentrate for solution for infusion - pemetrexed 25 mg/ml - antineoplastic agents
pemetrexed viatris 25 mg/ml concentrate for solution for infusion(40ml)
viatris limited damastown industrial park, mulhuddart, dublin 15, dublin, ireland - concentrate for solution for infusion - pemetrexed 25 mg/ml - antineoplastic agents
isoptin pr.tab 240mg/tab
viatris healthcare limited, ireland damastown industrial park, - dublin - verapamil hydrochloride - pr.tab (ΔΙΣΚΙΟ ΠΑΡΑΤΕΤΑΜΕΝΗΣ ΑΠΟΔΕΣΜΕΥΣΗΣ) - 240mg/tab - verapamil hydrochloride 240mg - verapamil
isoptin f.c.tab 40mg/tab
viatris healthcare limited, ireland damastown industrial park, - dublin - verapamil hydrochloride - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - 40mg/tab - verapamil hydrochloride 40mg - verapamil
isoptin f.c.tab 80mg/tab
viatris healthcare limited, ireland damastown industrial park, - dublin - verapamil hydrochloride - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - 80mg/tab - verapamil hydrochloride 80mg - verapamil
isoptin f.c.tab 120mg/tab
viatris healthcare limited, ireland damastown industrial park, - dublin - verapamil hydrochloride - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - 120mg/tab - verapamil hydrochloride 120mg - verapamil
tasmar
viatris healthcare limited - tolcapone - marda ta 'parkinson - kontra l-marda ta ' parkinson id-drogi, aġenti dopaminerġiċi oħra - tasmar hija indikata fil kombinazzjoni ma ' ticlopidine hydrochloride / benserazide jew ticlopidine hydrochloride / carbidopa għall-użu fil-pazjenti ma ticlopidine hydrochloride-responsivi idiopathic parkinson's marda u oxxillazzjonijiet vetturi bil-mutur, li naqas milli jirrispondi għal jew huma intolerant ta ' xulxin inibituri ta ' catechol-o-methyltransferase (comt). minħabba r-riskju ta potenzjalment fatali, ħsara fil-fwied akut, tasmar ma għandhomx jiġu kkunsidrati bħala l-ewwel linja ta 'trattament miżjud ma' levodopa / benserazide jew levodopa / carbidopa. peress li tasmar għandu jiġi użat biss flimkien ma 'levodopa / benserazide u b'levodopa / carbidopa, l-tagħrif preskritt individwalment għal dawn l-sustanzi ta' levodopa hija applikabbli għall-użu tagħhom flimkien ma ' tasmar.
cholib
viatris healthcare limited - fenofibrate, simvastatin - dislipidemije - sredstva za modifikaciju lipida - cholib je indiciran kao dodatna terapija dijeti i tjelovježbi u odraslih bolesnika visokim s mješovitim dislipidemijom za smanjenje triglicerida i povećanje razine hdl c kad ldl c razinama adekvatno upravlja pomoću odgovarajuće doze monoterapije simvastatinom.
tasmar
viatris healthcare limited - tolcapone - parkinson disease - anti-parkinson drugs, other dopaminergic agents - tasmar is indicated in combination with levodopa / benserazide or levodopa / carbidopa for use in patients with levodopa-responsive idiopathic parkinson’s disease and motor fluctuations, who failed to respond to or are intolerant of other catechol-o-methyltransferase (comt) inhibitors.because of the risk of potentially fatal, acute liver injury, tasmar should not be considered as a first-line adjunct therapy to levodopa / benserazide or levodopa / carbidopa.since tasmar should be used only in combination with levodopa / benserazide and levodopa / carbidopa, the prescribing information for these levodopa preparations is also applicable to their concomitant use with tasmar.